Abound Wealth Management Glaukos Corp Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
A detailed history of Abound Wealth Management transactions in Glaukos Corp stock. As of the latest transaction made, Abound Wealth Management holds 3 shares of GKOS stock, worth $306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 4
25.0%
Holding current value
$306
Previous $522,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
354Shares Held
47.9MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$820 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$609 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$210 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$197 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$149 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.85B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...